Stage IIIA Melanoma

Explore clinical trials studying Stage IIIA Melanoma. Study availability and eligibility vary by location and protocol.

9 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IIIA Melanoma trial results

Completed

Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma

NCT01321437

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +13 more
Locations: Chao Family Comprehensive Cancer Center Orange, California, United States

View Trial Details

Completed

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

NCT02094872

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: Mayo Clinic Cancer Center Scottsdale, Arizona, United States

Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States

Mayo Clinic Cancer Center Jacksonville, Florida, United States

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

NCT01748747

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +17 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

NCT02166255

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +40 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

NCT00003895

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +18 more
Locations: Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Completed

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

NCT00089063

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +23 more
Locations: University of Southern California Los Angeles, California, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT00470470

Conditions: Acral Lentiginous Malignant Melanoma, Melanoma, Neoplasms, +15 more
Locations: University of California at Los Angeles (UCLA ) Los Angeles, California, United States

Mount Sinai Medical Center CCOP Miami Beach, Florida, United States

Good Samaritan Medical Center West Palm Beach, Florida, United States

Palm Beach Cancer Institute-Main Office West Palm Beach, Florida, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

NCT00085189

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Extraocular Extension Melanoma, +31 more
Locations: University of Southern California Los Angeles, California, United States

View Trial Details

Completed

Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma

NCT00436605

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: Yale University New Haven, Connecticut, United States

Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Stage IIIA Melanoma

Stage IIIA Melanoma trial results

Related conditions